New Pradaxa Internal Bleeding Lawsuit Claims Drug Is Dangerous

A Florida man is claiming in a new lawsuit that within six months of taking the blood thinning medication Pradaxa, he was hospitalized for severe internal bleeding allegedly caused by the drug.

Benjamin Coy says that he began taking Pradaxa, manufactured by Boehringer Ingelheim, in May 2011 and was diagnosed with what he later found out were Pradaxa side effects in December of that year while he was in a hospital for treatment. His lawsuit alleges that the drug maker failed to adequately warn patients and doctors of the fact that Pradaxa bleeding side effects “are irreversible and have no antidote.”

While there are warnings of internal bleeding from Pradaxa, Coy’s Pradaxa side effects lawsuit notes that they are in the “Overdosage” section of the label. In addition, the lawsuit alleges that Pradaxa is defective by design because it “does not provide for patient-specific dosing” and has a higher rate of gastrointestinal bleeding compared to other options. Currently, the medication is only prescribed in two strengths.

In addition, the Pradaxa lawsuit alleges that “Pradaxa is not safer than (the competing drug) Coumadin. While offering some level of convenience from a safety perspective as compared to Coumadin, its risks greatly exceed any such convenience, which was the basic component in Defendants’ marketing launch.” Further, the Pradaxa lawsuit warns that “Patients can bleed to death internally without any hope of successful medical intervention.”

According to the Pradaxa lawsuit, Coy’s Pradaxa side effects are similar to those that afflicted hundreds of others who lost their lives since the medication was launched in 2010, with more than 250 deaths reported by the end of that year. Counts against the drug maker include strict liability, negligence, misrepresentation and gross negligence.

The Pradaxa gastrointestinal bleeding lawsuit is Benjamin Coy v. Boehringer Ingelheim Pharmaceuticals, et al., Case No. 13-cv-51563, in the U.S. District Court for the Southern District of Illinois.

Men and women who have faced problems with gastrointestinal bleeding, cerebral hemorrhaging or any other issues while taking this blood thinner for atrial fibrillation may be able to pursue compensatory damages from Boehringer. Learn more about what legal options are available by visiting the Pradaxa Internal Bleeding Class Action Lawsuit Investigation today. Filling out the short form there entitles people to a free case eligibility review with a Pradaxa side effects lawsuit attorney. Start today and find out what steps you can take if you’ve been the victim of bleeding events.

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.